Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$92.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dechra Pharmaceuticals PLC Declares Interim Dividend


Tuesday, 26 Feb 2013 02:00am EST 

Dechra Pharmaceuticals PLC announced that the Board of Director has declared an interim dividend of 4.34 pence per share (2011: 3.77 pence, restated after being adjusted for the bonus element of the Rights Issue), an increase of 15.1%. The dividend is payable on April 09, 2013 to Shareholders on the Register of Members at close of business on March 15, 2013. The ordinary shares will become ex dividend on March 13, 2013. 

Company Quote

823.125
-13.0 -1.56%
3:45am EST